On May 12, 2026, we detected 5 new cluster buys including a $20.3M purchase in $ODTX by 4 insiders, and 5 notable insider purchases. Li Nan (LN) (Director) bought $20.0M of $ODTX. Data sourced from SEC Form 4 filings analyzed by Average Insider.
⚠️ For information purposes only. This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 Insider Trading Insights — May 12, 2026
Tracking insider purchases and cluster buys over the past 7 days. Insider buying can indicate confidence in a company's future, while cluster buys (multiple insiders buying around the same time) are particularly noteworthy signals.
🔥 Cluster Buys
| | |
| Date Range May 08, 2026 – May 11, 2026 | |
👥 Participant Details
Haas Jason Chief Financial Officer | 1,000 shares $20,000 @ $20.00/share 2026-05-08T00:00:00 |
P&L: -12.8% ($2,550) | LEIDEN JEFFREY M Director | 5,000 shares $100,000 @ $20.00/share 2026-05-08T00:00:00 |
P&L: -12.8% ($12,750) |
Chu Shelley Director | 11,111 shares $199,998 @ $18.00/share 2026-05-11T00:00:00 |
P&L: -3.1% ($6,111) | Li Nan (LN) Director | 1,111,111 shares $19,999,998 @ $18.00/share 2026-05-11T00:00:00 |
P&L: -3.1% ($611,111) |
📰 Recent News (Last 7 Days)
| | |
| Date Range May 11, 2026 – May 11, 2026 | |
👥 Participant Details
DUGGAN ROBERT W Director | 660,233 shares $12,999,988 @ $19.69/share 2026-05-11T00:00:00 |
P&L: -3.1% ($402,742) | LAVIOLETTE PAUL A Director | 15,000 shares $295,350 @ $19.69/share 2026-05-11T00:00:00 |
P&L: -3.1% ($9,150) |
📊 Valuation & Analyst Info
Fair Value: $1.06 (-94.5% overvalued vs current price)
P/E Ratio: -12.7
Analyst Consensus: Buy
Price Target: $30.00 (Low: $30.00 | High: $30.00 | Median: $30.00)
📰 Recent News (Last 7 Days)
| | |
| Date Range May 11, 2026 – May 11, 2026 | |
👥 Participant Details
HARRINGTON WILLIAM T Director | 266,666 shares $3,999,990 @ $15.00/share 2026-05-11T00:00:00 |
P&L: -20.0% ($799,998) | HARRINGTON WILLIAM T Director | 266,667 shares $4,000,005 @ $15.00/share 2026-05-11T00:00:00 |
P&L: -20.0% ($800,001) |
Leavitt Chase C. General Counsel and Corporate Secretary | 3,000 shares $45,000 @ $15.00/share 2026-05-11T00:00:00 |
P&L: -20.0% ($9,000) | Lucchese Cynthia L Director | 125,000 shares $1,875,000 @ $15.00/share 2026-05-11T00:00:00 |
P&L: -20.0% ($375,000) |
Mead Dana G Jr. Director | 7,000 shares $105,000 @ $15.00/share 2026-05-11T00:00:00 |
P&L: -20.0% ($21,000) | |
📰 Recent News (Last 7 Days)
| | |
| Date Range May 07, 2026 – May 11, 2026 | |
👥 Participant Details
SIMPSON BOB R Director | 87,635 shares $1,089,680 @ $12.43/share 2026-05-07T00:00:00 |
P&L: +0.5% (+$5,758) | ADAMS WILLIAM H III Director | 10,000 shares $124,117 @ $12.41/share 2026-05-08T00:00:00 |
P&L: +0.7% (+$883) |
SIMPSON BOB R Director | 162,365 shares $2,030,066 @ $12.50/share 2026-05-08T00:00:00 |
P&L: -0.0% ($503) | SIMPSON BOB R Director | 500,000 shares $6,336,750 @ $12.67/share 2026-05-11T00:00:00 |
P&L: -1.4% ($86,750) |
📊 Valuation & Analyst Info
Fair Value: $-218.95 (-1851.6% overvalued vs current price)
P/E Ratio: -24.6
Analyst Consensus: Strong Buy
Price Target: $18.00 (Low: $18.00 | High: $18.00 | Median: $18.00)
📰 Recent News (Last 7 Days)
| | |
| Date Range May 06, 2026 – May 08, 2026 | |
👥 Participant Details
CULP H LAWRENCE JR Director | 80,805 shares $5,000,076 @ $61.88/share 2026-05-06T00:00:00 |
P&L: -0.3% ($14,408) | Stromberg William J Director | 1,000 shares $61,689 @ $61.69/share 2026-05-06T00:00:00 |
P&L: +0.0% (+$11) |
Yang Watkin Phoebe L. Director | 1,000 shares $63,006 @ $63.01/share 2026-05-08T00:00:00 |
P&L: -2.1% ($1,306) | |
📊 Valuation & Analyst Info
Fair Value: $170.85 (+176.9% undervalued vs current price)
P/E Ratio: 18.0 (0.4x below Medical - Healthcare Information Services avg (29.0)) (0.3x below Healthcare avg (24.7))
Analyst Consensus: Buy
Price Target: $84.00 (Low: $65.00 | High: $105.00 | Median: $85.00)
📰 Recent News (Last 7 Days)
💰 Individual Insider Buys
Transaction Date May 11, 2026 | | |
Purchase Value $19,999,998 | | |
📰 Recent News (Last 7 Days)
Transaction Date May 11, 2026 | | |
Purchase Value $12,999,988 | | |
📊 Valuation & Analyst Info
Fair Value: $1.06 (-94.5% overvalued vs current price)
P/E Ratio: -12.7
Analyst Consensus: Buy
Price Target: $30.00 (Low: $30.00 | High: $30.00 | Median: $30.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-11
Transaction Date May 11, 2026 | | |
Purchase Value $10,020,903 | | |
📊 Valuation & Analyst Info
Fair Value: $-171.93 (-534.0% overvalued vs current price)
P/E Ratio: -166.4
Analyst Consensus: Buy
Price Target: $96.43 (Low: $70.00 | High: $150.00 | Median: $85.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-04
Transaction Date May 11, 2026 | | |
| | |
📊 Valuation & Analyst Info
Fair Value: $-171.93 (-534.0% overvalued vs current price)
P/E Ratio: -166.4
Analyst Consensus: Buy
Price Target: $96.43 (Low: $70.00 | High: $150.00 | Median: $85.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-04
Transaction Date May 11, 2026 | | |
| | |
📊 Valuation & Analyst Info
Fair Value: $-218.95 (-1851.6% overvalued vs current price)
P/E Ratio: -24.6
Analyst Consensus: Strong Buy
Price Target: $18.00 (Low: $18.00 | High: $18.00 | Median: $18.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-04
⚠️ Important Disclaimers
Investment Disclaimer: This content is for informational purposes only and should not be considered investment advice.
Data Accuracy: All information is sourced from SEC filings and third-party data providers. Errors or omissions may occur.
Market Risks: Past insider buying activity does not guarantee future performance.
Professional Advice: Consult with qualified financial professionals before making any investment decisions.